Taejoon Pharm wins patent lawsuit against GE Healthcare
Published: 2008-04-11 06:52:00
Updated: 2008-04-11 06:52:00
The Supreme Court ruled that Taejoon Pharm did not used patent-covered injection technology of contrast media developed by General Electric Healthcare, ending a three-year-long legal battle between the Korean firm and the U.S. company.
In the ruling, the court said that Taejoon has not infring...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
